Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-071-3 | CAS number: 10028-18-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
ACUTE ORAL TOXICITY: An LD50 for acute oral toxicity of 310.2 mg NiF2*4H2O has been identified from the Eurofin 2008 study. This value correseponds to 178 mg/Kg bw of Nickel fluoride anhydrous
ACUTE INHALATION TOXICITY: An LC50 for acute inhalation toxicity of 2.48 mg NiSO4.6H2O/L air for males and females has been identified from the EPSL 2009 study. This value corresponds to 0.91 mg/L of Nickel Fluoride, i.e. 910 mg/m3
ACUTE DERMAL TOXICITY: No proper acute dermal studies with nickel sulphate have been found. Nickel sulphate was tested on volunteers in 1979 and a 20% water solution resulted as irritant. New testing by the dermal route has been waived as described below and under Section 7.2.3 of IUCLID.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 178 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 910 mg/m³
Additional information
An LD50 for acute oral toxicity of 310 mg NiF2.4H2O from Eurofin 2008 study is used for the risk characterisation.
A background document describing the use of Ni sulfate as a source substance for read-across to other nickel compounds has been attached to Section 7.2.1 of IUCLID.
An LC50 for acute inhalation toxicity of 2.48 mg NiSO4.6H2O/L air for males and females has been identified from the EPSL 2009 study. A background document describing the use of Ni sulfate as a source substance for read-across to other nickel compounds for acute oral and acute inhalation toxicity has been attached to Section 7.2.2.
There are no available data on which to evaluate acute dermal toxicity. However, acute toxicity is expected to be low in view of the poor absorption by this route. In addition, please note the following in regards to REACH endpoint requirements identified in Column 2 of the REACH Annex VIII which state,
"in addition to the oral route (8.5.1), for substances other than gases, the information mentioned under 8.5.2 to 8.5.3 [inhalation and dermal acute toxicity] shall be provided for at least one other route. The choice for the second route will depend on the nature of the substance and the likely route of human exposure. If there is only one route of exposure, information for only that route need be provided”. The rules for adaptation also state that, “Testing by the dermal route is appropriate if…(1) inhalation of the substance is unlikely…”.
As oral and inhalation routes of exposure are more relevant and data for these have been provided, testing for acute dermal toxicity is therefore waived based on this information.
FOR AN EXTENSIVE DISCUSSION, REFER TO THE NICKEL SULFATE DOSSIER WHICH IS BASED ON THE CONCLUSIONS EXPLAINED IN THE 2008/2009 EUROPEAN UNION EXISITING SUBSTANCE RISK ASSESSMENT OF NICKEL (EU RAR) (EEC 793/93)
Justification for classification or non-classification
Acute oral toxicity
A newly conducted GLP OECD guideline compliant study reported an LD50 =310 mg/kg for Ni fluoride tetrahydrate, which corresponds to 178 mg/kg bw of Nickel fluoride anhydrous: The classification for acute oral toxicity as Xn; R23 and Acute Tox. 3; H301.
Acute inhalation toxicity
As data were not available at the time of classification, the EU Risk Assessment based the classification for acute inhalation toxicity on read-across from the oral data. However, a newly conducted GLP OECD guideline compliant study reported an LC50 =2.48 mg/L for Ni sulfate hexahydrate as aerosolised dust. This value corresponds to LC50=0.91 mg/L for nickel fluoride anhydrous. This value is used to justify the classification as T: R25 and Acute Tox. 3: H331 for acute inhalation toxicity.
Acute dermal toxicity
There is no data on toxicity following cutaneous administration. Dermal absorption is expected to be very limited. Therefore, this endpoint is not considered in the risk characterisation and no classification for acute toxicity via the dermal route is proposed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live2